$ASAP #Asarina Pharma Asarina Pharma (Buy, TP: SEK61.00) - Disappointing top-line results: Asarina Pharma announced yesterday evening that the study in PMDD failed to meet its primary and secondary endpoints. An unexpectedly high placebo… https://t.co/BK0sspRogg #equity #stocks